Deep brain stimulation for obsessive–compulsive disorders: long-term analysis of quality of life

Objective To evaluate the long-term effects of deep brain stimulation (DBS) on quality of life (QOL) in therapy-refractory obsessive–compulsive disorder (OCD) patients. Design 16 patients who met Diagnostic and Statistical Manual of Mental Disorders (4th ed) (DSM-IV) criteria for OCD and were considered therapy-refractory were treated with DBS. Patients were assessed 1 month before device implantation (T0), at 8 months of active stimulation (T1) and at 3–5 years of active stimulation (T2). QOL was measured with the WHO Quality of Life Scale-Brief Version (WHOQOL-BREF) that covers physical, psychological, social and environmental domains. The study was conducted between April 2005 and January 2011 at the Academic Medical Center, Amsterdam, The Netherlands. Results At T1 and T2, we found significant improvement (p<0.05) in the general score and in the physical, psychological and environmental domains of WHOQOL-BREF. Between T1 and T2, the physical and psychological domains improved further (p<0.05). At T2, the general score improved by a total of 90%, the physical and psychological domains both improved by 39.5% and the environmental domain improved by 16%. The social domain did not change between baseline and follow-up assessments. Conclusions In line with symptom improvement, patient's QOL improved in the general score and in three of the four WHOQOL-BREF domains. This suggests that the improvement caused by DBS is not limited to symptom reduction alone, but also has a positive influence on patients’ perception of their physical, psychological, environmental and global QOL. Clinical trial registration http://isrctn.org identifier: ISRCTN23255677.

[1]  M. Vink,et al.  Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder , 2013, Nature Neuroscience.

[2]  V. Starcevic,et al.  Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49years , 2011, Psychiatry Research.

[3]  D. Denys,et al.  Current Status of Deep Brain Stimulation for Obsessive-Compulsive Disorder: A Clinical Review of Different Targets , 2011, Current psychiatry reports.

[4]  H. Westenberg,et al.  Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. , 2010, Archives of general psychiatry.

[5]  C. Yen,et al.  Quality of Life and its Correlates in Patients With Obsessive‐compulsive Disorder , 2010, The Kaohsiung journal of medical sciences.

[6]  B. Greenberg,et al.  Deep Brain Stimulation for Intractable Obsessive Compulsive Disorder: Pilot Study Using a Blinded, Staggered-Onset Design , 2010, Biological Psychiatry.

[7]  V. Sturm,et al.  Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year , 2010, Clinical Neurology and Neurosurgery.

[8]  Michael X. Cohen,et al.  Nucleus Accumbens Deep Brain Stimulation Decreases Ratings of Depression and Anxiety in Treatment-Resistant Depression , 2010, Biological Psychiatry.

[9]  Shailendra Kapoor,et al.  Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. , 2009, The New England journal of medicine.

[10]  H. Katschnig Quality of life in mental disorders: challenges for research and clinical practice. , 2006, World psychiatry : official journal of the World Psychiatric Association.

[11]  Leonardo Franklin Fontenelle,et al.  Clinical features associated to refractory obsessive-compulsive disorder. , 2006, Journal of affective disorders.

[12]  G. Manfro,et al.  A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. , 2006, The Journal of clinical psychiatry.

[13]  D. Denys Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. , 2006, The Psychiatric clinics of North America.

[14]  M. Angermeyer,et al.  Subjective quality of life of patients with obsessive–compulsive disorder , 2006, Social Psychiatry and Psychiatric Epidemiology.

[15]  G. V. van Heck,et al.  Quality of Life and Psychopathology: Investigations into their Relationship , 2006, The Australian and New Zealand journal of psychiatry.

[16]  J. Vries,et al.  Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients , 2005, Quality of Life Research.

[17]  E. Heldt,et al.  Cognitive-Behavioral Group Therapy in Obsessive-Compulsive Disorder: A Randomized Clinical Trial , 2003, Psychotherapy and Psychosomatics.

[18]  M. Power,et al.  Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment , 1998, Psychological Medicine.

[19]  Andrew C. Leon,et al.  Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale , 1997, International journal of psychiatry in medicine.

[20]  D. Sheehan,et al.  The measurement of disability , 1996, International clinical psychopharmacology.

[21]  T. Silverstone,et al.  The effects of D‐ and L‐fenfluramine (and their interactions with D‐amphetamine) on psychomotor function and mood , 1996, International clinical psychopharmacology.

[22]  Suck-Won Kim,et al.  The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.

[23]  K J Rothman,et al.  No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.

[24]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[25]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.

[26]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[27]  M. Hamilton The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.

[28]  Dan J Stein,et al.  The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication , 2010, Molecular Psychiatry.

[29]  G. Friehs,et al.  Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience , 2010, Molecular Psychiatry.

[30]  Y. Akvardar,et al.  [Quality of life in patients with obsessive-compulsive disorder: relations with cognitive functions and clinical symptoms]. , 2005, Turk psikiyatri dergisi = Turkish journal of psychiatry.

[31]  I. Heuser,et al.  The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. , 1988, Journal of affective disorders.